Cancer

UK charities: The funding giants of medical research

One notable quirk of the British life sciences ecosystem is the importance of its not-for-profit sector. Indeed, in 2017, UK charities poured GBP 1.6 billion (USD 2.1 billion) into medical…

Euratom: Where Are We Now?

Hamid Yunis, partner and head of healthcare at the London office of international law firm, McDermott Will &…

Novartis: EU approve gene-modifying cancer therapy

This week Novartis received approval from the European Commission (EC) for Kymriah, their chimeric antigen…

Korean Research Team Develops Nanoparticle for Cancer Treatment

A Korean research team at Ulsan National Institute of Science and Technology (UNIST) have developed a cunning…

In Conversation

Maria Begona Barragan Garcia, president of GEPAC – the Spanish Group of Patients with Cancer – discusses the necessity of the group and its role in Spain’s healthcare system, in addition to how the voice of the patients is now stronger than ever. GEPAC represents 88 different cancer organizations and we now have a strong voice in Spain’s healthcare…

Orphan Drugs in Europe: A Snapshot

125 medicines for rare diseases were approved by the EMA between 2004 and 2014, of which 71 were granted orphan…

Cannabinoid Drugs, Medicinal Cannabis & Opioid Drugs: Greece

Cannabinoid Drugs, Medicinal Cannabis & Opioid Drugs in Greece – the complete legal lowdown. Prepared in…

NHS approves ‘game-changing’ cell therapy for children with cancer

Novartis receives NHS approval for their CAR T-cell therapy to treat leukaemia in children, 10 days after…

Dying to Survive

This week, China has fast-tracked approval for 48 “much-needed medicines.” Regulators gave special…

Turkey: The Future of Cancer Care Uncertain

Turkey has one of the most revered Social Security Systems in the world, providing its citizens with…

Korea’s Government-Funded Venture into Oncology

National OncoVenture (NOV) is Korea’s Ministry of Health and Welfare funded oncology drug development program to…

Celltrion Wins Big Deal for Breast Cancer Biosimilar in French Hospitals

Celltrion Healthcare, the marketing arm of the biopharmaceutical company Celltrion won a huge deal in France last…

Bristol-Myers Squibb to Acquire Celgene to Expand its Cancer Portfolio

Last week, Bristol-Myers Squibb (BMS) announced that they have entered into a definitive merger agreement under…